BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 27574422)

  • 1. Aptamer-functionalized peptide H3CR5C as a novel nanovehicle for codelivery of fasudil and miRNA-195 targeting hepatocellular carcinoma.
    Liu Y; Wu X; Gao Y; Zhang J; Zhang D; Gu S; Zhu G; Liu G; Li X
    Int J Nanomedicine; 2016; 11():3891-905. PubMed ID: 27574422
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Polyethylene glycol-poly(ε-benzyloxycarbonyl-l-lysine)-conjugated VEGF siRNA for antiangiogenic gene therapy in hepatocellular carcinoma.
    Wang G; Gao X; Gu G; Shao Z; Li M; Wang P; Yang J; Cai X; Li Y
    Int J Nanomedicine; 2017; 12():3591-3603. PubMed ID: 28533682
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lipid-modified cell-penetrating peptide-based self-assembly micelles for co-delivery of narciclasine and siULK1 in hepatocellular carcinoma therapy.
    Wang X; Wu F; Li G; Zhang N; Song X; Zheng Y; Gong C; Han B; He G
    Acta Biomater; 2018 Jul; 74():414-429. PubMed ID: 29787814
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeting ROCK1/2 blocks cell division and induces mitotic catastrophe in hepatocellular carcinoma.
    Wu H; Chen Y; Li B; Li C; Guo J; You J; Hu X; Kuang D; Qi S; Liu P; Li L; Xu C
    Biochem Pharmacol; 2021 Feb; 184():114353. PubMed ID: 33278350
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enhanced anti-tumor effect of liposomal Fasudil on hepatocellular carcinoma in vitro and in vivo.
    Zhao Y; Zhang Y; Vazirinejad Mehdiabad M; Zhou K; Chen Y; Li L; Guo J; Xu C
    PLoS One; 2019; 14(10):e0223232. PubMed ID: 31581236
    [TBL] [Abstract][Full Text] [Related]  

  • 6. SP94 Peptide-Functionalized PEG-PLGA Nanoparticle Loading with Cryptotanshinone for Targeting Therapy of Hepatocellular Carcinoma.
    Nie X; Liu Y; Li M; Yu X; Yuan W; Huang S; Ren D; Wang Y; Wang Y
    AAPS PharmSciTech; 2020 Apr; 21(4):124. PubMed ID: 32342227
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antitumor effect of vascular endothelial growth factor inhibitor sunitinib in preclinical models of hepatocellular carcinoma.
    Bagi CM; Gebhard DF; Andresen CJ
    Eur J Gastroenterol Hepatol; 2012 May; 24(5):563-74. PubMed ID: 22314934
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Suppression of vascular endothelial growth factor via inactivation of eukaryotic elongation factor 2 by alkaloids in Coptidis rhizome in hepatocellular carcinoma.
    Tan HY; Wang N; Tsao SW; Zhang Z; Feng Y
    Integr Cancer Ther; 2014 Sep; 13(5):425-34. PubMed ID: 24363282
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel therapeutic potential in targeting microtubules by nanoparticle albumin-bound paclitaxel in hepatocellular carcinoma.
    Zhou Q; Ching AK; Leung WK; Szeto CY; Ho SM; Chan PK; Yuan YF; Lai PB; Yeo W; Wong N
    Int J Oncol; 2011 Mar; 38(3):721-31. PubMed ID: 21240457
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of VEGF165/VEGFR2-dependent signaling by LECT2 suppresses hepatocellular carcinoma angiogenesis.
    Chen CK; Yu WH; Cheng TY; Chen MW; Su CY; Yang YC; Kuo TC; Lin MT; Huang YC; Hsiao M; Hua KT; Hung MC; Kuo ML
    Sci Rep; 2016 Aug; 6():31398. PubMed ID: 27507763
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glycyrrhetinic Acid-Mediated Polymeric Drug Delivery Targeting the Acidic Microenvironment of Hepatocellular Carcinoma.
    Zhang J; Zhang M; Ji J; Fang X; Pan X; Wang Y; Wu C; Chen M
    Pharm Res; 2015 Oct; 32(10):3376-90. PubMed ID: 26148773
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A supramolecular nanoparticle system based on β-cyclodextrin-conjugated poly-l-lysine and hyaluronic acid for co-delivery of gene and chemotherapy agent targeting hepatocellular carcinoma.
    Xiong Q; Cui M; Bai Y; Liu Y; Liu D; Song T
    Colloids Surf B Biointerfaces; 2017 Jul; 155():93-103. PubMed ID: 28411478
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modified AS1411 Aptamer Suppresses Hepatocellular Carcinoma by Up-Regulating Galectin-14.
    Cho Y; Lee YB; Lee JH; Lee DH; Cho EJ; Yu SJ; Kim YJ; Kim JI; Im JH; Lee JH; Oh EJ; Yoon JH
    PLoS One; 2016; 11(8):e0160822. PubMed ID: 27494117
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Paclitaxel-loaded nanoparticles decorated with bivalent fragment HAb18 F(ab')
    Jin C; Bai L; Lin L; Wang S; Yin X
    Artif Cells Nanomed Biotechnol; 2018 Aug; 46(5):1076-1084. PubMed ID: 28776396
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cell-penetrating Peptide-modified Targeted Drug-loaded Phase-transformation Lipid Nanoparticles Combined with Low-intensity Focused Ultrasound for Precision Theranostics against Hepatocellular Carcinoma.
    Zhao H; Wu M; Zhu L; Tian Y; Wu M; Li Y; Deng L; Jiang W; Shen W; Wang Z; Mei Z; Li P; Ran H; Zhou Z; Ren J
    Theranostics; 2018; 8(7):1892-1910. PubMed ID: 29556363
    [No Abstract]   [Full Text] [Related]  

  • 16. The Rho kinase inhibitor fasudil is involved in p53-mediated apoptosis in human hepatocellular carcinoma cells.
    Takeba Y; Matsumoto N; Watanabe M; Takenoshita-Nakaya S; Ohta Y; Kumai T; Takagi M; Koizumi S; Asakura T; Otsubo T
    Cancer Chemother Pharmacol; 2012 Jun; 69(6):1545-55. PubMed ID: 22481618
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 2-Methoxyestradiol synergizes with sorafenib to suppress hepatocellular carcinoma by simultaneously dysregulating hypoxia-inducible factor-1 and -2.
    Ma L; Li G; Zhu H; Dong X; Zhao D; Jiang X; Li J; Qiao H; Ni S; Sun X
    Cancer Lett; 2014 Dec; 355(1):96-105. PubMed ID: 25218350
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PEG-coated nanoparticles detachable in acidic microenvironments for the tumor-directed delivery of chemo- and gene therapies for head and neck cancer.
    Lo YL; Chang CH; Wang CS; Yang MH; Lin AM; Hong CJ; Tseng WH
    Theranostics; 2020; 10(15):6695-6714. PubMed ID: 32550898
    [No Abstract]   [Full Text] [Related]  

  • 19. Regulatory mechanisms and therapeutic targeting of vasculogenic mimicry in hepatocellular carcinoma.
    Zheng N; Zhang S; Wu W; Zhang N; Wang J
    Pharmacol Res; 2021 Apr; 166():105507. PubMed ID: 33610718
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aptamer and Peptide-Modified Lipid-Based Drug Delivery Systems in Application of Combined Sequential Therapy of Hepatocellular Carcinoma.
    Jianghong L; Tingting M; Yingping Z; Tong Y; Lanxia Z; Jingwen L; Wentao Z; Pengbo C; Hong Y; Fuqiang H
    ACS Biomater Sci Eng; 2021 Jun; 7(6):2558-2568. PubMed ID: 34047187
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.